These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
224 related items for PubMed ID: 31974274
1. Epitope and Fc-Mediated Cross-linking, but Not High Affinity, Are Critical for Antitumor Activity of CD137 Agonist Antibody with Reduced Liver Toxicity. Ho SK, Xu Z, Thakur A, Fox M, Tan SS, DiGiammarino E, Zhou L, Sho M, Cairns B, Zhao V, Xiong M, Samayoa J, Forsyth CM, Powers DB, Chao DT, Hollenbaugh D, Alvarez HM, Akamatsu Y. Mol Cancer Ther; 2020 Apr; 19(4):1040-1051. PubMed ID: 31974274 [Abstract] [Full Text] [Related]
11. The emerging landscape of novel 4-1BB (CD137) agonistic drugs for cancer immunotherapy. Claus C, Ferrara-Koller C, Klein C. MAbs; 2023 Mar 12; 15(1):2167189. PubMed ID: 36727218 [Abstract] [Full Text] [Related]
12. Treatment with anti-CD137 mAbs causes intense accumulations of liver T cells without selective antitumor immunotherapeutic effects in this organ. Dubrot J, Milheiro F, Alfaro C, Palazón A, Martinez-Forero I, Perez-Gracia JL, Morales-Kastresana A, Romero-Trevejo JL, Ochoa MC, Hervás-Stubbs S, Prieto J, Jure-Kunkel M, Chen L, Melero I. Cancer Immunol Immunother; 2010 Aug 12; 59(8):1223-33. PubMed ID: 20336294 [Abstract] [Full Text] [Related]
17. A Multifunctional Role for Adjuvant Anti-4-1BB Therapy in Augmenting Antitumor Response by Chimeric Antigen Receptor T Cells. Mardiana S, John LB, Henderson MA, Slaney CY, von Scheidt B, Giuffrida L, Davenport AJ, Trapani JA, Neeson PJ, Loi S, Haynes NM, Kershaw MH, Beavis PA, Darcy PK. Cancer Res; 2017 Mar 15; 77(6):1296-1309. PubMed ID: 28082401 [Abstract] [Full Text] [Related]
18. Antitumor efficacy and reduced toxicity using an anti-CD137 Probody therapeutic. Etxeberria I, Bolaños E, Teijeira A, Garasa S, Yanguas A, Azpilikueta A, Kavanaugh WM, Vasiljeva O, Belvin M, Howng B, Irving B, Tipton K, West J, Mei L, Korman AJ, Sega E, Olivera I, Cirella A, Ochoa MC, Rodriguez ME, Melero A, Sanmamed MF, Engelhardt JJ, Melero I. Proc Natl Acad Sci U S A; 2021 Jun 29; 118(26):. PubMed ID: 34172583 [Abstract] [Full Text] [Related]
19. Therapeutic effect of CD137 immunomodulation in lymphoma and its enhancement by Treg depletion. Houot R, Goldstein MJ, Kohrt HE, Myklebust JH, Alizadeh AA, Lin JT, Irish JM, Torchia JA, Kolstad A, Chen L, Levy R. Blood; 2009 Oct 15; 114(16):3431-8. PubMed ID: 19641184 [Abstract] [Full Text] [Related]
20. CD1d-based combination therapy eradicates established tumors in mice. Teng MW, Sharkey J, McLaughlin NM, Exley MA, Smyth MJ. J Immunol; 2009 Aug 01; 183(3):1911-20. PubMed ID: 19620318 [Abstract] [Full Text] [Related] Page: [Next] [New Search]